CUSTOMER SUCCESS STORY | LIFE SCIENCES CDMO
A Fortune 200 CDMO Recovered $2.4M in Inventory Exposure and Compressed E&O Review Cycles from Nine Months to Two Weeks
How a Fortune 200 life sciences contract manufacturer rebuilt its E&O inventory governance around Tryft Traceflow.
CUSTOMER PROFILE
Industry
Life Sciences Contract Manufacturing (CDMO)
Scale
Fortune 200, multi-site operations
Complexity
Dozens of customer programs across commercial and clinical phases, with frequent forecast and packaging changes
Functions
Supply Chain, Procurement, Warehouse, Finance, Commercial
Reference Name
“LifeScience1” (anonymized)
AT A GLANCE
$2.4M
Customer-driven exposure recovered in Year 1
50%
Reduction in inventory at risk
9 mo → 2 wk
E&O review cycle compression
2,200+
Analyst hours redeployed annually
5
Functions on a single risk view
$700K
Recovered via automated storage chargebacks
Executive Summary
For a Fortune 200 CDMO, excess and obsolete (E&O) inventory is a structural drag on working capital and a recurring source of customer friction. LifeScience1 had spent years managing it reactively through spreadsheets, email chains, and quarterly review meetings.
Traceflow gave the company a continuous operating layer that surfaces inventory risk as it forms, attributes exposure to the responsible customer program, and routes recovery workflows across finance, supply chain, and commercial in days rather than quarters.
“We weren’t short on data. We were short on a way to act on it before the inventory expired or the customer changed their mind again.”
— VP, Global Supply Chain, LifeScience1
The Problem
Customer portfolios in life sciences have become more volatile. Biologics and specialty therapies move through accelerated development paths, packaging specs shift constantly, and working capital tied up in customer-specific materials has grown faster than most CDMOs’ inventory governance has evolved. LifeScience1’s CFO had flagged inventory reserves as a recurring earnings concern. Every customer forecast revision or packaging change created exposure that should contractually have been recoverable. The exposure was real. The recovery process was broken.
Before Traceflow, inventory analysts spent most of their week reconciling ERP extracts against forecasts, packaging change notices, and procurement records trying to answer four operationally simple but analytically painful questions:
-
Which customer program caused this exposure?
-
Was the material purchased specifically against their demand?
-
Can the inventory be repurposed, transferred, or sold back?
-
How much of the liability is contractually recoverable?
Answering those questions across thousands of SKUs took the better part of a fiscal quarter. By the time exposure was quantified, the inventory had often expired and the recovery window had closed.
2,200+ hrs
Analyst hours per year spent on manual E&O analysis producing reports, not decisions.
A Representative Failure
One pattern repeated often enough to become a leadership focus. A customer would issue a packaging artwork change. Procurement had typically already purchased six to twelve months of the previous component. The obsolete inventory sat in storage, accruing cost and approaching expiry, while the team manually traced the change order, the purchase commitment, the contractual recovery clause, and the customer contact authorized to acknowledge the chargeback.
In one representative case, a packaging change traced and recovered manually took 142 days. The same change pattern, after Traceflow, is now surfaced within 48 hours of the customer’s notice with exposure quantified and recovery routed.
Why Tryft?
LifeScience1 evaluated three paths: extending the ERP, building internally on their data warehouse, or partnering with a purpose-built platform. The ERP path was 18–24 months and would have produced reporting, not workflow. The internal build lacked the cross-functional logic approvals, customer attribution, recovery routing that the use case actually required.
Traceflow was selected because it operationalized the response to risk, not just the detection of it routing approvals, triggering chargeback workflows, and recommending repurposing or transfer actions in the same surface where the exposure was identified.
“We didn’t need another dashboard. We needed a system that closed the loop that turned a risk signal into a recovery action with an owner and a deadline.”
— Director, Supply Chain Transformation, LifeScience1
Implementation
Traceflow was deployed in a phased rollout, starting with the two highest-complexity manufacturing sites. ERP integration completed in the first quarter, with customer master data and contractual chargeback terms loaded in parallel. A cross-functional working group defined the workflow logic for attribution and recovery routing.
The most significant change was organizational. Finance moved from downstream observer of write-offs to upstream participant in exposure decisions. Commercial teams gained direct visibility into the inventory implications of customer change requests, shifting those conversations earlier in the lifecycle.
Outcomes
Working Capital and Financial Recovery
In the first twelve months, LifeScience1 recovered $1.7M in customer-driven exposure that would previously have been written off, plus $700K through automated storage fee chargebacks. Inventory reserves declined and working capital visibility for customer-specific components improved materially.
Operational Velocity
The E&O review cycle compressed from six to nine months to under two weeks. More than 30 hours per week of analyst time was redirected from spreadsheet reconciliation to forecasting, customer engagement, and procurement strategy.
Risk Posture and Governance
Raw material and packaging inventory at risk declined by 50% — driven by earlier detection, not by demand changes. Five functions now operate from a shared inventory risk view, with audit-ready workflow trails supporting regulatory and customer contract obligations.
Before
6–9 month review cycles producing retrospective reports
After
2-week cycles producing live, attributable recovery actions.
What Changed Beyond the Numbers
Customer change orders no longer trigger weeks of internal reconciliation; they trigger an attributed exposure workflow within hours. Finance is engaged at the point of risk formation, not at quarter-end close. Commercial teams now carry inventory accountability into customer conversations rather than discovering exposure after the fact.
In an industry where customer-driven volatility is structural rather than episodic, the shift from retrospective to continuous inventory governance isn’t a process improvement. It’s an operating model change.
Looking Forward
LifeScience1 is expanding Traceflow across additional sites and into procurement scenario planning and supplier-side exposure management building toward a unified inventory and customer liability operating layer that scales with customer complexity, not analyst headcount.
ABOUT TRYFT TRACEFLOW
Tryft Traceflow is an inventory risk and recovery platform purpose-built for complex, customer-driven manufacturing environments. It connects ERP, demand, procurement, and customer master data into a continuous operating layer that surfaces exposure as it forms, attributes it to the responsible program, and routes recovery workflows across supply chain, finance, procurement, and commercial functions.